Accessibility Menu
Crescent Biopharma Stock Quote

Crescent Biopharma (NASDAQ: CBIO)

$12.65
(1.0%)
+0.12
Price as of October 21, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$12.65
Daily Change
(1.0%) +$0.12
Day's Range
$12.42 - $12.98
Previous Close
$12.65
Open
$12.56
Beta
0.92
Volume
56,366
Average Volume
118,159
Market Cap
175.7M
Market Cap / Employee
$12.65M
52wk Range
$9.81 - $63
Revenue
-
Gross Margin
-4.85%
Dividend Yield
N/A
EPS
-$35.72
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Crescent Biopharma Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
CBIO-20.94%-96.07%-47.66%-21%
S&P+15.06%+95.03%+14.29%+12%

Crescent Biopharma Company Info

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.

Financial Health

General

Q2 2025YOY Change
Revenue$0.00M0.0%
Gross Profit-$0.00M83.9%
Gross Margin-132.97%0.0%
Market Cap$10.42M-42.6%
Market Cap / Employee$0.32M0.0%
Employees330.0%
Net Income-$21.79M-115.8%
EBITDA-$21.03M-103.3%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$152.65M581.9%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$1.43M0.0%
Short Term Debt$0.21M-53.0%

Ratios

Q2 2025YOY Change
Return On Assets-45.29%45.4%
Return On Invested Capital-206.72%-135.2%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$22.30M-150.7%
Operating Free Cash Flow-$22.16M-149.2%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book0.963.024.013.09391.53%
Price to Sales15196.9519337.171815.871089.78-
Price to Tangible Book Value95.79141.14254.853.09-95.08%
Enterprise Value to EBITDA0.57-1.02-3.314.031003.45%
Return on Equity-137.2%-173.2%-182.7%-51.7%-50.53%
Total Debt$0.26M$0.07M$0.00M$1.64M266.33%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.